NCT00901693View on ClinicalTrials.gov

An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Adenoviral Conjunctivitis
Interventions
DRUG

AL-46383A Ophthalmic Solution

DRUG

AL-46383A Ophthalmic Solution Vehicle

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00901693 - An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis | Biotech Hunter | Biotech Hunter